224 related articles for article (PubMed ID: 19420351)
1. High prevalence of dysfibrinogenemia among patients with chronic thromboembolic pulmonary hypertension.
Morris TA; Marsh JJ; Chiles PG; Magaña MM; Liang NC; Soler X; Desantis DJ; Ngo D; Woods VL
Blood; 2009 Aug; 114(9):1929-36. PubMed ID: 19420351
[TBL] [Abstract][Full Text] [Related]
2. Fibrinogen Aα Thr312Ala polymorphism specifically contributes to chronic thromboembolic pulmonary hypertension by increasing fibrin resistance.
Li JF; Lin Y; Yang YH; Gan HL; Liang Y; Liu J; Yang SQ; Zhang WJ; Cui N; Zhao L; Zhai ZG; Wang J; Wang C
PLoS One; 2013; 8(7):e69635. PubMed ID: 23894515
[TBL] [Abstract][Full Text] [Related]
3. Chronic thromboembolic pulmonary hypertension-associated dysfibrinogenemias exhibit disorganized fibrin structure.
Marsh JJ; Chiles PG; Liang NC; Morris TA
Thromb Res; 2013; 132(6):729-34. PubMed ID: 24182551
[TBL] [Abstract][Full Text] [Related]
4. Fibrinogen Aalpha Thr312Ala polymorphism is associated with chronic thromboembolic pulmonary hypertension.
Suntharalingam J; Goldsmith K; van Marion V; Long L; Treacy CM; Dudbridge F; Toshner MR; Pepke-Zaba J; Eikenboom JC; Morrell NW
Eur Respir J; 2008 Apr; 31(4):736-41. PubMed ID: 18057060
[TBL] [Abstract][Full Text] [Related]
5. Identification of the Novel Variants in Patients With Chronic Thromboembolic Pulmonary Hypertension.
Yaoita N; Satoh K; Satoh T; Shimizu T; Saito S; Sugimura K; Tatebe S; Yamamoto S; Aoki T; Kikuchi N; Kurosawa R; Miyata S; Nagasaki M; Yasuda J; Shimokawa H
J Am Heart Assoc; 2020 Nov; 9(21):e015902. PubMed ID: 33103541
[TBL] [Abstract][Full Text] [Related]
6. Two cases of congenital dysfibrinogenemia associated with thrombosis - Fibrinogen Praha III and Fibrinogen Plzen.
Kotlín R; Reicheltová Z; Malý M; Suttnar J; Sobotková A; Salaj P; Hirmerová J; Riedel T; Dyr JE
Thromb Haemost; 2009 Sep; 102(3):479-86. PubMed ID: 19718467
[TBL] [Abstract][Full Text] [Related]
7. Two novel fibrinogen variants in the C-terminus of the Bβ-chain: fibrinogen Rokycany and fibrinogen Znojmo.
Kotlín R; Reicheltová Z; Suttnar J; Salaj P; Hrachovinová I; Riedel T; Malý M; Oravec M; Kvasnicka J; Dyr JE
J Thromb Thrombolysis; 2010 Oct; 30(3):311-8. PubMed ID: 20640913
[TBL] [Abstract][Full Text] [Related]
8. Chronic Thromboembolic Pulmonary Hypertension Cases Cluster in Families.
Dodson MW; Allen-Brady K; Brown LM; Elliott CG; Cannon-Albright LA
Chest; 2019 Feb; 155(2):384-390. PubMed ID: 30732691
[TBL] [Abstract][Full Text] [Related]
9. Fibrinogen Nový Jicín and Praha II: cases of hereditary Aalpha 16 Arg-->Cys and Aalpha 16 Arg-->His dysfibrinogenemia.
Kotlín R; Chytilová M; Suttnar J; Riedel T; Salaj P; Blatný J; Santrůcek J; Klener P; Dyr JE
Thromb Res; 2007; 121(1):75-84. PubMed ID: 17408725
[TBL] [Abstract][Full Text] [Related]
10. Hypodysfibrinogenemia: A novel abnormal fibrinogen associated with bleeding and thrombotic complications.
Amri Y; Kallel C; Becheur M; Dabboubi R; Elloumi M; Belaaj H; Kammoun S; Messaoud T; de Moerloose P; Toumi Nel H
Clin Chim Acta; 2016 Sep; 460():55-62. PubMed ID: 27343352
[TBL] [Abstract][Full Text] [Related]
11. Confirmation of mendelian properties of heterodimeric fibrinogen molecules in a heterozygotic dysfibrinogenemia, "fibrinogen Amarillo," using gprphoresis to differentiate semifibrin molecules from fibrinogen and fibrin.
Shainoff JR; Ratnoff OD; Smejkal GB; DiBello PM; Welches WR; Lill H; Mitkevich OV; Periman P
Thromb Res; 2001 Jan; 101(2):91-9. PubMed ID: 11342210
[TBL] [Abstract][Full Text] [Related]
12. A novel mutation in the fibrinogen Aα chain (Gly13Arg, fibrinogen Nanning) causes congenital dysfibrinogenemia associated with defective peptide A release.
Yan J; Luo M; Cheng P; Liao L; Deng X; Deng D; Lin F
Int J Hematol; 2017 Apr; 105(4):506-514. PubMed ID: 27933517
[TBL] [Abstract][Full Text] [Related]
13. Molecular Research in Chronic Thromboembolic Pulmonary Hypertension.
Opitz I; Kirschner MB
Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30759794
[TBL] [Abstract][Full Text] [Related]
14. [A case of dysfibrinogenemia without hemorrhagic diathesis or thromboembolism linked to a new mutation p.H103N in fibrinogen γ chain].
Devignes J; Hanss M; Chabaud A; Toussaint-Hacquard M; Mansuy L; De Mazancourt P; Lecompte T
Ann Biol Clin (Paris); 2013; 71(4):489-95. PubMed ID: 23906582
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism. Prevalence of CTEPH after pulmonary embolism.
Guérin L; Couturaud F; Parent F; Revel MP; Gillaizeau F; Planquette B; Pontal D; Guégan M; Simonneau G; Meyer G; Sanchez O
Thromb Haemost; 2014 Sep; 112(3):598-605. PubMed ID: 24898545
[TBL] [Abstract][Full Text] [Related]
16. Dusart Syndrome in a Scandinavian family characterized by arterial and venous thrombosis at young age.
Ramanathan R; Gram J; Feddersen S; Nybo M; Larsen A; Sidelmann JJ
Scand J Clin Lab Invest; 2013 Oct; 73(7):585-90. PubMed ID: 24000886
[TBL] [Abstract][Full Text] [Related]
17. Risk factors detection in chronic thromboembolic pulmonary hypertension, a tool for risk quantification?
Bohacekova M; Kaldararova M; Valkovicova T; Remkova A; Vesely J; Simkova I
Bratisl Lek Listy; 2016; 117(10):577-582. PubMed ID: 27826972
[TBL] [Abstract][Full Text] [Related]
18. Hereditary and acquired thrombotic risk factors for chronic thromboembolic pulmonary hypertension.
Wong CL; Szydlo R; Gibbs S; Laffan M
Blood Coagul Fibrinolysis; 2010 Apr; 21(3):201-6. PubMed ID: 20182352
[TBL] [Abstract][Full Text] [Related]
19. The fibrinogen Aalpha R16C mutation results in fibrinolytic resistance.
Flood VH; Al-Mondhiry HA; Farrell DH
Br J Haematol; 2006 Jul; 134(2):220-6. PubMed ID: 16846481
[TBL] [Abstract][Full Text] [Related]
20. Fibrinogen Mahdia: A congenitally abnormal fibrinogen characterized by defective fibrin polymerization.
Amri Y; Jouini H; Becheur M; Dabboubi R; Mahjoub B; Messaoud T; Sfar MT; Casini A; de Moerloose P; Toumi NEH
Haemophilia; 2017 Jul; 23(4):e340-e347. PubMed ID: 28594476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
